Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene. Counted 2026-11-11.
Most papers first521 to 540 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| TBP TATA-box binding protein | 6908 HGNC:11588 | 1 | 60 | 0 | 0 | 7,690 | 13,907 |
| AMH anti-Mullerian hormone | 268 HGNC:464 | 1 | 49 | 0 | 0 | 2,122 | 13,861 |
| PCSK9 proprotein convertase subtilisin/kexin type 9 | 255738 HGNC:20001 | 1 | 346 | 11 | 189 | 4,687 | 13,851 |
| FASN fatty acid synthase | 2194 HGNC:3594 | 1 | 68 | 0 | 0 | 6,097 | 13,826 |
| LPA lipoprotein(a) | 4018 HGNC:6667 | 1 | 38 | 2 | 6 | 3,840 | 13,816 |
| MLC1 modulator of VRAC current 1 | 23209 HGNC:17082 | 1 | 39 | 0 | 0 | 6,636 | 13,796 |
| RIGI RNA sensor RIG-I | 23586 HGNC:19102 | 1 | 57 | 0 | 0 | 6,482 | 13,728 |
| MYCN MYCN proto-oncogene, bHLH transcription factor | 4613 HGNC:7559 | 1 | 90 | 0 | 0 | 5,477 | 13,678 |
| HLA-DQB1 major histocompatibility complex, class II, DQ beta 1 | 3119 HGNC:4944 | 1 | 42 | 0 | 0 | 5,211 | 13,659 |
| OCLN occludin | 100506658 HGNC:8104 | 1 | 86 | 0 | 0 | 5,032 | 13,631 |
| TGFBR2 transforming growth factor beta receptor 2 | 7048 HGNC:11773 | 1 | 310 | 0 | 0 | 6,908 | 13,618 |
| PRTN3 proteinase 3 | 5657 HGNC:9495 | 1 | 124 | 0 | 0 | 2,607 | 13,610 |
| FCGR1A Fc gamma receptor Ia | 2209 HGNC:3613 | 1 | 455 | 2 | 1 | 6,780 | 13,606 |
| CYP2B6 cytochrome P450 family 2 subfamily B member 6 | 1555 HGNC:2615 | 1 | 53 | 0 | 0 | 5,045 | 13,584 |
| CD9 CD9 molecule | 928 HGNC:1709 | 1 | 163 | 0 | 0 | 5,093 | 13,577 |
| BTK Bruton tyrosine kinase | 695 HGNC:1133 | 1 | 108 | 24 | 898 | 4,550 | 13,552 |
| LIF LIF interleukin 6 family cytokine | 3976 HGNC:6596 | 1 | 201 | 0 | 0 | 6,613 | 13,533 |
| VIP vasoactive intestinal peptide | 7432 HGNC:12693 | 1 | 103 | 0 | 0 | 5,351 | 13,532 |
| FOLH1 folate hydrolase 1 | 2346 HGNC:3788 | 1 | 480 | 9 | 116 | 3,361 | 13,509 |
| CALR calreticulin | 811 HGNC:1455 | 1 | 203 | 0 | 0 | 5,566 | 13,484 |
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=27
{
"data": {
"total": 193990,
"results": [
{
"id": "6908",
"title": "TBP: TATA-box binding protein",
"summary": "NCBI Gene 6908. 1 protein, 60 patents, 0 drugs, 0 trials, 7,690 NIH grants and 13,907 papers.",
"record": "/library/genes/6908",
"gene_id": 6908,
"symbol": "TBP",
"name": "TATA-box binding protein",
"hgnc_id": "HGNC:11588",
"counts": {
"proteins": 1,
"patents": 60,
"drugs": 0,
"trials": 0,
"grants": 7690,
"papers": 13907
}
},
{
"id": "268",
"title": "AMH: anti-Mullerian hormone",
"summary": "NCBI Gene 268. 1 protein, 49 patents, 0 drugs, 0 trials, 2,122 NIH grants and 13,861 papers.",
"record": "/library/genes/268",
"gene_id": 268,
"symbol": "AMH",
"name": "anti-Mullerian hormone",
"hgnc_id": "HGNC:464",
"counts": {
"proteins": 1,
"patents": 49,
"drugs": 0,
"trials": 0,
"grants": 2122,
"papers": 13861
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "None stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "None named. Public domain as US government information"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=28",
"request_id": "LbNn9QGCj0ZVdiGp"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant